Episode Details
Back to Episodes
Pharmaceutical Executive Daily: FDA Approves Pasatru
Published 2 months, 4 weeks ago
Description
A partnership roundup covers deals from IntraGel Therapeutics/UroGen Pharma and Lupin/Tenpoint Therapeutics, FDA approves Regeneron's Pasatru for fibrodysplasia ossificans progressiva, and RELEX's Rohit Tripathi discusses reshoring pharma manufacturing.